Peter Kotsonis

1.3k total citations
28 papers, 1.1k citations indexed

About

Peter Kotsonis is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Peter Kotsonis has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Physiology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Peter Kotsonis's work include Nitric Oxide and Endothelin Effects (13 papers), Neuroscience and Neuropharmacology Research (7 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Peter Kotsonis is often cited by papers focused on Nitric Oxide and Endothelin Effects (13 papers), Neuroscience and Neuropharmacology Research (7 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Peter Kotsonis collaborates with scholars based in Australia, Germany and United Kingdom. Peter Kotsonis's co-authors include Harald Schmidt, L. Fröhlich, H. Majewski, Martin Feelisch, Wolfgang Pfleiderer, Bernd Clement, Helmut E. Meyer, Suzanne M. Lohmann, Albert Sickmann and Albert Smolenski and has published in prestigious journals such as Journal of Biological Chemistry, Circulation Research and Biochemical Journal.

In The Last Decade

Peter Kotsonis

27 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Kotsonis Australia 16 628 407 201 181 157 28 1.1k
Walter R. Kukovetz Austria 22 802 1.3× 476 1.2× 413 2.1× 232 1.3× 31 0.2× 40 1.3k
LL Thomsen United Kingdom 9 768 1.2× 414 1.0× 90 0.4× 310 1.7× 24 0.2× 9 1.5k
Luyun Zou United States 16 294 0.5× 909 2.2× 184 0.9× 44 0.2× 112 0.7× 24 1.4k
Toshie Kambe Japan 17 247 0.4× 373 0.9× 281 1.4× 38 0.2× 63 0.4× 29 784
Jia Ying United States 6 364 0.6× 621 1.5× 202 1.0× 199 1.1× 29 0.2× 6 1.0k
Tetsuhiro Hisayama Japan 19 432 0.7× 459 1.1× 185 0.9× 70 0.4× 43 0.3× 70 853
Xiaoyong Tong United States 17 368 0.6× 584 1.4× 276 1.4× 124 0.7× 37 0.2× 21 1.2k
C. van Breemen United States 22 533 0.8× 966 2.4× 388 1.9× 50 0.3× 90 0.6× 32 1.5k
Yin Hua Zhang South Korea 23 452 0.7× 660 1.6× 887 4.4× 94 0.5× 90 0.6× 78 1.6k
Ivan Milicic United States 19 202 0.3× 554 1.4× 164 0.8× 29 0.2× 103 0.7× 42 1.1k

Countries citing papers authored by Peter Kotsonis

Since Specialization
Citations

This map shows the geographic impact of Peter Kotsonis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kotsonis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kotsonis more than expected).

Fields of papers citing papers by Peter Kotsonis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kotsonis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kotsonis. The network helps show where Peter Kotsonis may publish in the future.

Co-authorship network of co-authors of Peter Kotsonis

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kotsonis. A scholar is included among the top collaborators of Peter Kotsonis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kotsonis. Peter Kotsonis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matter, Hans & Peter Kotsonis. (2004). Biology and chemistry of the inhibition of nitric oxide synthases by pteridine‐derivatives as therapeutic agents. Medicinal Research Reviews. 24(5). 662–684. 15 indexed citations
2.
Scotland, Ramona S., Sharmila D. Chauhan, Clare Davis, et al.. (2004). Vanilloid Receptor TRPV1, Sensory C-Fibers, and Vascular Autoregulation. Circulation Research. 95(10). 1027–1034. 120 indexed citations
3.
Savidge, Jonathan R., Clare Davis, Kirti Shah, et al.. (2002). Cloning and functional characterization of the guinea pig vanilloid receptor 1. Neuropharmacology. 43(3). 450–456. 80 indexed citations
4.
Kotsonis, Peter, et al.. (2001). Differential abilities of phorbol esters in inducing protein kinase C (PKC) down‐regulation in noradrenergic neurones. British Journal of Pharmacology. 132(2). 489–499. 5 indexed citations
5.
Kotsonis, Peter, L. Fröhlich, C.S. Raman, et al.. (2001). Structural Basis for Pterin Antagonism in Nitric-oxide Synthase. Journal of Biological Chemistry. 276(52). 49133–49141. 24 indexed citations
6.
Kotsonis, Peter, et al.. (2000). Modulation of acetylcholine release from mouse cortex by protein kinase C. Life Sciences. 67(1). 31–38. 5 indexed citations
7.
Butt, Elke, Albert Smolenski, Peter Kotsonis, et al.. (2000). Endothelial Nitric-oxide Synthase (Type III) Is Activated and Becomes Calcium Independent upon Phosphorylation by Cyclic Nucleotide-dependent Protein Kinases. Journal of Biological Chemistry. 275(7). 5179–5187. 235 indexed citations
8.
Reif, Andreas, L. Fröhlich, Peter Kotsonis, et al.. (1999). Tetrahydrobiopterin Inhibits Monomerization and Is Consumed during Catalysis in Neuronal NO Synthase. Journal of Biological Chemistry. 274(35). 24921–24929. 91 indexed citations
9.
Murphy, Timothy V., et al.. (1999). Structural determinants of phorbol ester binding in synaptosomes: pharmacokinetics and pharmacodynamics. European Journal of Pharmacology. 381(1). 77–84. 16 indexed citations
10.
Kotsonis, Peter, et al.. (1999). The structural requirements for phorbol esters to enhance serotonin and acetylcholine release from rat brain cortex. British Journal of Pharmacology. 127(5). 1177–1189. 5 indexed citations
11.
Kotsonis, Peter, L. Fröhlich, Heinrich Hofmann, et al.. (1999). Autoinhibition of neuronal nitric oxide synthase: distinct effects of reactive nitrogen and oxygen species on enzyme activity. Biochemical Journal. 340(3). 745–752. 37 indexed citations
13.
Majewski, H., et al.. (1997). PROTEIN KINASE C AND TRANSMITTER RELEASE. Clinical and Experimental Pharmacology and Physiology. 24(8). 619–623. 13 indexed citations
14.
Majewski, H., et al.. (1997). Noradrenaline release and the effect of endogenous activation of the phospholipase C/protein kinase C signalling pathway in rat atria. British Journal of Pharmacology. 121(6). 1196–1202. 9 indexed citations
15.
Kotsonis, Peter, et al.. (1996). Noradrenaline synthesis after sympathetic nerve activation in rat atria and its dependence on calcium but not CAM kinase II and protein kinases A or C. British Journal of Pharmacology. 119(8). 1605–1613. 1 indexed citations
16.
Kotsonis, Peter & H. Majewski. (1996). The structural requirements for phorbol esters to enhance noradrenaline and dopamine release from rat brain cortex. British Journal of Pharmacology. 119(1). 115–125. 18 indexed citations
17.
Noshiro, Takao, Toshiya Watanabe, Peter Kotsonis, et al.. (1995). EFFECTS OF ISOTONIC SALINE LOADING ON RENAL TUBULAR AND NEUROGENIC DOPAMINE RELEASE IN CONSCIOUS RABBITS. Clinical and Experimental Pharmacology and Physiology. 22(6-7). 469–471. 8 indexed citations
18.
Kotsonis, Peter, et al.. (1995). Protein kinase C involvement in maintenance and modulation of noradrenaline release in the mouse brain cortex. British Journal of Pharmacology. 116(6). 2757–2763. 15 indexed citations
19.
Jones, Stephen B., Peter Kotsonis, & H. Majewski. (1994). ENDOTOXIN ENHANCES NOREPINEPHRINE RELEASE IN THE RAT BY PERIPHERAL MECHANISMS. Shock. 2(5). 370–375. 16 indexed citations
20.
Kotsonis, Peter & H. Majewski. (1994). Facilitation by procaterol, a β‐adrenoceptor agonist, of noradrenaline release in the pithed rat independently of angiotensin II formation. British Journal of Pharmacology. 113(3). 781–788. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026